U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H31NO3
Molecular Weight 357.4864
Optical Activity ( - )
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Aroxybutynin

SMILES

CCN(CC)CC#CCOC(=O)[C@@](O)(C1CCCCC1)C2=CC=CC=C2

InChI

InChIKey=XIQVNETUBQGFHX-QFIPXVFZSA-N
InChI=1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3/t22-/m0/s1

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
[Non-coordinated micturition syndrome mimicking posterior urethral valves in a male neonate].
2003 Jul
Acupressure versus oxybutinin in the treatment of enuresis.
2003 Nov-Dec
Oxybutynin extended-release: a review of its use in the management of overactive bladder.
2004
High performance liquid chromatographic determination of oxeladin citrate and oxybutynin hydrochloride and their degradation products.
2005 Aug
Prediction of genotoxicity of chemical compounds by statistical learning methods.
2005 Jun
Formulation and optimization of porous osmotic pump-based controlled release system of oxybutynin.
2007 Jul 13
Primary monosymptomatic nocturnal enuresis in children and adolescents.
2007 Sep
Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve.
2007 Sep
The neurogenic bladder: medical treatment.
2008 May
Generation of an agonistic binding site for blockers of the M(3) muscarinic acetylcholine receptor.
2008 May 15
Locked-in Syndrome in a Nigerian male with Multiple Sclerosis: a case report and literature review.
2008 Oct 30
Reversible bilateral optic neuritis after Infliximab discontinuation in a patient with Crohn's disease.
2009 Sep
Urological manifestations of Chikungunya fever: A single centre experience.
2010 Sep
Dose escalation improves therapeutic outcome: post hoc analysis of data from a 12-week, multicentre, double-blind, parallel-group trial of trospium chloride in patients with urinary urge incontinence.
2010 Sep 14
Patents
Name Type Language
Aroxybutynin
INN  
Official Name English
(-)-OXYBUTYNIN
Common Name English
OXYBUTYNIN, (-)-
Common Name English
4-(diethylamino)but-2-yn-1-yl (R)-cyclohexyl(hydroxy)(phenyl)acetate
Systematic Name English
(R)-OXYBUTYNIN
Common Name English
Benzeneacetic acid, α-cyclohexyl-α-hydroxy-, 4-(diethylamino)-2-butyn-1-yl ester, (αR)-
Systematic Name English
aroxybutynin [INN]
Common Name English
R-OXYBUTYNIN
Common Name English
OXYBUTYNIN, (R)-
Common Name English
Code System Code Type Description
FDA UNII
5BRQ29UUB7
Created by admin on Sat Dec 16 19:33:24 UTC 2023 , Edited by admin on Sat Dec 16 19:33:24 UTC 2023
PRIMARY
CAS
119618-21-2
Created by admin on Sat Dec 16 19:33:24 UTC 2023 , Edited by admin on Sat Dec 16 19:33:24 UTC 2023
PRIMARY
SMS_ID
300000045599
Created by admin on Sat Dec 16 19:33:24 UTC 2023 , Edited by admin on Sat Dec 16 19:33:24 UTC 2023
PRIMARY
INN
12152
Created by admin on Sat Dec 16 19:33:24 UTC 2023 , Edited by admin on Sat Dec 16 19:33:24 UTC 2023
PRIMARY
PUBCHEM
6098167
Created by admin on Sat Dec 16 19:33:24 UTC 2023 , Edited by admin on Sat Dec 16 19:33:24 UTC 2023
PRIMARY
NCI_THESAURUS
C190351
Created by admin on Sat Dec 16 19:33:24 UTC 2023 , Edited by admin on Sat Dec 16 19:33:24 UTC 2023
PRIMARY